Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
394
-
Total 13F shares, excl. options
-
80.1M
-
Shares change
-
+198K
-
Total reported value, excl. options
-
$9.18B
-
Value change
-
-$53.9M
-
Put/Call ratio
-
1.5
-
Number of buys
-
198
-
Number of sells
-
-201
-
Price
-
$114.52
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q2 2023
523 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2023.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 394 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.1M shares
of 106M outstanding shares and own 75.84% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.53M shares), BlackRock Inc. (5.5M shares), JANUS HENDERSON GROUP PLC (5.45M shares), Avoro Capital Advisors LLC (4.63M shares), JPMORGAN CHASE & CO (4.4M shares), WELLINGTON MANAGEMENT GROUP LLP (3.86M shares), EcoR1 Capital, LLC (3.66M shares), Bank of New York Mellon Corp (2.43M shares), STATE STREET CORP (1.91M shares), and FMR LLC (1.8M shares).
This table shows the top 394 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.